Abstract
The palladium-catalyzed reaction of 5-(4-hydroxyphenyl)-1,2,4-oxadiazoles with ethyl α-O-Δ2-glucopyranoside afforded ethyl 4-O-[4-(1,2,4-oxadiazol-5-yl)phenyl]-2,3-dideoxy-α-D-erythro-hex-2-enopyranosides. Bishydroxylation of the latter compounds gave the corresponding ethyl 4-O-[4-(1,2,4-oxadiazol-5-yl)phenyl]-α-Dmannopyranosides.
Keywords: 1,2,4-Oxadiazole, palladium catalyst, ethyl α-O-Δ2-glycoside, ethyl mannopyranoside
Letters in Organic Chemistry
Title: Synthesis of Ethyl 4-O-[4-(1,2,4-Oxadiazol-5-yl)phenyl]-α-D-mannopyranosides
Volume: 4 Issue: 6
Author(s): Janaina Versiani dos Anjos, Denis Sinou, Sebastiao Jose de Melo and Rajendra Mohan Srivastava
Affiliation:
Keywords: 1,2,4-Oxadiazole, palladium catalyst, ethyl α-O-Δ2-glycoside, ethyl mannopyranoside
Abstract: The palladium-catalyzed reaction of 5-(4-hydroxyphenyl)-1,2,4-oxadiazoles with ethyl α-O-Δ2-glucopyranoside afforded ethyl 4-O-[4-(1,2,4-oxadiazol-5-yl)phenyl]-2,3-dideoxy-α-D-erythro-hex-2-enopyranosides. Bishydroxylation of the latter compounds gave the corresponding ethyl 4-O-[4-(1,2,4-oxadiazol-5-yl)phenyl]-α-Dmannopyranosides.
Export Options
About this article
Cite this article as:
Janaina Versiani dos Anjos , Denis Sinou , Sebastiao Jose de Melo and Rajendra Mohan Srivastava , Synthesis of Ethyl 4-O-[4-(1,2,4-Oxadiazol-5-yl)phenyl]-α-D-mannopyranosides, Letters in Organic Chemistry 2007; 4 (6) . https://dx.doi.org/10.2174/157017807781467579
DOI https://dx.doi.org/10.2174/157017807781467579 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Central Blood Pressure in Chronic Kidney Disease: Latest Evidence and Clinical Relevance
Current Hypertension Reviews Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds
Current Bioactive Compounds Relaxin as a Cardiovascular Drug: A Promise Kept
Current Drug Safety Anti-Inflammatory Role of Thyroid Hormones on Rat Air Pouch Model of Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) The Role of Angiotensin in Obesity and Metabolic Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets An Infrared Reflection-Absorption Spectroscopic (IRRAS) Study of the Interaction of Lipid A and Lipopolysaccharide Re with Endotoxin-Binding Proteins
Medicinal Chemistry Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening
Current Pharmaceutical Design Editorial [ Medicines Da Vinci Code: Deciphering the Intricate Origins of Clinical Neurovascular Pathology K. Maiese ]
Current Neurovascular Research Protein Tyrosine Phosphatase as Potential Therapeutic Target in various Disorders
Current Molecular Pharmacology The G Protein β3 Subunit Gene (GNB3) 825T Allele - a Thrifty Genotype
Current Genomics Perinatal Management of Fetal Tumors
Current Pediatric Reviews Early Postoperative Bleeding in Polytrauma Patients Treated with Fondaparinux: Literature Review and Institutional Experience
Current Vascular Pharmacology Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways
Current Cancer Drug Targets Neuroprotection of (+)-2-(1-Hydroxyl-4-Oxocyclohexyl) Ethyl Caffeate Against Hydrogen Peroxide and Lipopolysaccharide Induced Injury via Modulating Arachidonic Acid Network and p38-MAPK Signaling
Current Alzheimer Research Piroxicam: Source for Synthesis of Central Nervous System (CNS) Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Meta Analysis of Advanced Cancer Survival Data Using Lognormal Parametric Fitting: A Statistical Method to Identify Effective Treatment Protocols
Current Pharmaceutical Design Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies
Current Drug Metabolism Thalidomide Analogues as Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery